Pro Health Tips
Tuesday, 27 August 2019
New Drug Combination Has Potential to Treat Non-small Cell Lung Cancer
Moffitt Cancer Center study finds combination treatment of pembrolizumab and vorinostat is well tolerated, showing preliminary efficacy of therapy for lung cancer patients.
from Medindia Health News https://ift.tt/2NAyzgz
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Moffitt Cancer Center study finds combination treatment of pembrolizumab and vorinostat is well tolerated, showing preliminary efficacy of therapy for lung cancer patients.
No comments:
Post a Comment